Document Preview Unavailable

Pharmacokinetics, pharmacodynamics, and safety of GS‐3583, a FLT3 agonist Fc fusion protein, from single‐ascending‐dose phase I study in healthy participants

Dauki, Anees M; Rajakumaraswamy, Nishanthan; Trowe, Torsten; Weng, Winnie; Lin, Kai‐Wen; et al.  Clinical and Translational Science Vol. 17, Iss. 8,  (Aug 1, 2024).

You might have access to this document